Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/WBIO stock hub

CSE/WBIO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/WBIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

324.8K

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/WBIO

In the news

Latest news · CSE/WBIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/WBIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

112

Groups with data

Currency

CAD

Showing 112 of 112 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	16
Employees Change	-7%
Employees Change Percent	-30.43
Enterprise value	CAD 706,303
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA92941F2044
Last refreshed	2026-05-10
Market cap	CAD 324,763
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/WBIO
Website	https://www.wpdpharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.06%
EV Earnings	-105.32x
P/B ratio	-0.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -6,706
Net Income Growth Quarters	2%
Profit Per Employee	CAD -419
ROA	-71.58
Roa5y	-127.3
ROCE	115.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Quarters	2

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 292,535
Cash	CAD 9,339
Current Assets	CAD 57,001
Current Liabilities	CAD 544,444
Debt	CAD 390,880
Equity	CAD -622,289
Interest Coverage	-4.93
Liabilities	CAD 914,824
Long Term Assets	CAD 235,534
Long Term Liabilities	CAD 370,380
Net Cash	CAD -381,541
Net Cash By Market Cap	CAD -117
Tangible Book Value	CAD -622,289
Tangible Book Value Per Share	CAD -0.13
WACC	8.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.1
Net Working Capital	CAD -476,282
Quick ratio	0.1
Working Capital	CAD -487,443

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	1.13
All Time High Change	-93.78%
All Time High Date	2024-05-24
All Time Low	0.07
All Time Low Change	0%
All Time Low Date	2025-02-20
ATR	0.06
Beta	0.14
Beta1y	0
Beta2y	-0.05
Ch YTD	-41.67
High	0.07
High52	1.13
High52 Date	2024-05-24
High52ch	-93.78%
Low	0.07
Low52	0.07
Low52 Date	2025-05-08
Low52ch	0%
RSI	39.2
RSI Monthly	0
RSI Weekly	5.29
Sharpe ratio	1.65x
Sortino ratio	4.54
Total Return	-0.57%
Tr YTD	-41.67
Tr3m	-63.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -290,036

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-2,335
Shares Out	4,639,475
Shares Qo Q	1.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,503.4x
Bv Per Share	-0.13
Ch3m	-63.16
Ch6m	-44
Change	-63.16%
Change From Open	0
Close	0.19
Days Gap	-63.16
Depreciation Amortization	4,941
Dollar Volume	560
Earnings Date	2026-05-15
EBIT	CAD -290,036
EBITDA	CAD -285,095
EPS	CAD -0
F Score	0
Financing CF	30,500
Fiscal Year End	December
Investing CF	7,368
Is Primary Listing	1
Last Earnings Date	2025-12-12
Last Report Date	2024-09-30
Last Split Date	2024-12-30
Last Split Type	Reverse
Ma20	0.15
Ma20ch	-53.83%
Net CF	-134,119
Next Earnings Date	2026-05-15
Open	0.07
Price Date	2025-02-20
Relative Volume	2.28x
Tr6m	-44%
Volume	8,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/WBIO pay a dividend?

Capital-return profile for this ticker.

Technical

CSE/WBIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

0.14

Less volatile than the market

Sharpe ratio

1.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/WBIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/WBIO stock rating?

cse/WBIO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/WBIO analysis?

The full report lives at /stocks/cse/WBIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/WBIO?

The latest report frames cse/WBIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/WBIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.